Publications by authors named "Daniel Castrillejo"

Claim this Profile
E
Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain.
Ayelén Rojas-Benedicto, Gloria Pérez-Gimeno, Jacobo Mendioroz, Irene Pedrosa Corral, Miriam López Torrijos, Daniel Castrillejo

Expert Rev Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case-control study, Spain, October 2024-March 2025.
Sandra Campos Mena, Gloria Pérez-Gimeno, Nicola Lorusso, Virginia Álvarez Río, Luca Basile, Daniel Castrillejo

Epidemiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing Epidemic and Intensity Thresholds After a Major Change in Respiratory Virus Surveillance in Spain in 2020.
Ana María Puerto, José Eugenio Lozano, Marcos Lozano, Luca Basile, Gael Naveira-Barbeito, Daniel Castrillejo

Influenza Other Respir Viruses· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased trends in reported sexually transmitted infections according to age groups and sex in Spain, 2016-2022.
Victoria Hernando, Nicola Lorusso, Carmen Montaño, An Ld Boone, Antonia Garí, Daniel Castrillejo

Infect Dis (Lond)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.
Lorena Vega-Piris, Silvia Galindo Carretero, José Luis Mayordomo, Mercedes Belén Rumayor Zarzuelo, Virginia Álvarez Río, Daniel Castrillejo

J Infect· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024.
Lore Merdrignac, Charlotte Laniece Delaunay, Nuno Verdasca, Lorena Vega-Piris, Joan O'Donnell, Daniel Castrillejo

Influenza Other Respir Viruses· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.
Gloria Pérez-Gimeno, Clara Mazagatos, Nicola Lorusso, Luca Basile, Isabel Martínez-Pino, Daniel Castrillejo

Euro Surveill· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006-2021.
Victoria Hernando, Lucia Suárez, Gonzalo Gutiérrez, Juan Carlos López, Roser Navarro-Soler, Daniel Castrillejo

Enferm Infecc Microbiol Clin (Engl Ed)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
Clara Mazagatos, Jacobo Mendioroz, Mercedes Belén Rumayor, Virtudes Gallardo García, Virginia Álvarez Río, Daniel Castrillejo

Influenza Other Respir Viruses· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
Jesús Castilla, Manuel García Cenoz, Raquel Abad, Laura Sánchez-Cambronero, Nicola Lorusso, Daniel Castrillejo

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Esther Kissling, Francisco Pozo, Iván Martínez-Baz, Silke Buda, Ana-Maria Vilcu, Daniel Castrillejo

Influenza Other Respir Viruses· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022.
Berta Suárez Rodríguez, Bernardo R Guzmán Herrador, Asunción Díaz Franco, María Paz Sánchez-Seco Fariñas, Julia Del Amo Valero, Daniel Castrillejo

Emerg Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for COVID-19 management in reception centers for refugees, asylum seekers, and migrants, Spain 2020.
Andreas Hoefer, Despina Pampaka, Daniel Castrillejo, José Luengo-Cabrera, Martha Paisi

Int J Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.
Marta Ruiz-Algueró, Victoria Hernando, Henar Marcos, Gonzalo Gutiérrez, Maria Jesus Pérez-Elías, Daniel Castrillejo

BMC Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years' experience, Spain, 1998 to 2015.
Josefa Masa-Calles, Nuria Torner, Noemí López-Perea, María de Viarce Torres de Mier, Beatriz Fernández-Martínez, Daniel Castrillejo

Euro Surveill· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in young people at risk of exclusion in Melilla (Spain).
Daniel Castrillejo, Carlos Muñoz-Bravo, Antonio García-Rodríguez, José Ruiz-Olivares, Mario Gutiérrez-Bedmar

Gac Sanit· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
Alin Gherasim, Francisco Pozo, Salvador de Mateo, Inma Aspiritxaga Gamarra, Manuel García-Cenoz, Daniel Castrillejo

Vaccine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus].
Asuncion Diaz, Alicia Ten, Henar Marcos, Gonzalo Gutiérrez, Juan González-García, Daniel Castrillejo

Enferm Infecc Microbiol Clin· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.
Silvia Jiménez-Jorge, Salvador de Mateo, Concha Delgado-Sanz, Francisco Pozo, Inmaculada Casas, Daniel Castrillejo

BMC Infect Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis